The combination of fludarabine and intravenous busulfan (IVFB) has a more favorable toxicity profile and overall outcome than fludarabine and melphalan (FM) as reduced-intensity conditioning prior to allogeneic stem-cell transplantation (SCT)

被引：0
|
作者：
Shimoni, A [1 ]
Yeshurun, M [1 ]
Hardan, I [1 ]
Shem-Tov, N [1 ]
Avigdor, A [1 ]
Ben-Bassat, I [1 ]
Nagler, A [1 ]
机构：
[1] Chaim Sheba Med Ctr, IL-52621 Tel Hashomer, Israel
来源：
EXPERIMENTAL HEMATOLOGY | 2004年 / 32卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
127
引用
收藏
页码：61 / 61
页数：1
相关论文
共 50 条
  • [11] Impact of age on outcome after allogeneic hematopoietic stem cell transplantation using reduced-intensity conditioning with Fludarabine/Busulfan
    Bethge, W. A.
    Federmann, B.
    Helwig, A.
    Faul, C.
    Vogel, W.
    Kanz, L.
    ONKOLOGIE, 2012, 35 : 129 - 129
  • [12] Reduced-Intensity Conditioning with Busulfan and Fludarabine for Allogeneic Hematopoietic Stem Cell Transplantation in Acute Lymphoblastic Leukemia
    Lee, Seung-Shin
    Jung, Sung-Hoon
    Do, Young Rok
    Kim, Dae Sik
    Lee, Ji Hyun
    Park, Han-Seung
    Moon, Joon Ho
    Yi, Jun Ho
    Park, Yong
    Koh, Youngil
    Yhim, Ho-Young
    Choi, Yunsuk
    Mun, Yeung-Chul
    Lee, Won-Sik
    Lee, Seok
    Yang, Deok-Hwan
    YONSEI MEDICAL JOURNAL, 2020, 61 (06) : 452 - 459
  • [13] Oral versus Intravenous Fludarabine as Part of a Reduced-Intensity Conditioning for Allogeneic Stem Cell Transplantation
    Velazquez-Sanchez-de-Cima, Sara
    Zamora-Ortiz, Gabriela
    Hernandez-Reyes, Jesus
    Daniel Rosales-Duron, Alan
    Patricia Gonzalez-Ramirez, Monica
    Angela Martagon-Herrera, Nora
    Ruiz-Delgado, Guillermo J.
    Ruiz-Argueelles, Guillermo J.
    ACTA HAEMATOLOGICA, 2014, 132 (01) : 125 - 128
  • [14] Reduced-intensity conditioning with treosulfan and fludarabine for allogeneic hematopoietic stem cell transplantation
    Nihtinen, A
    Volin, L
    Juvonen, E
    Ruutu, T
    BONE MARROW TRANSPLANTATION, 2003, 31 : S159 - S159
  • [15] Favorable outcome for patients with myeloid disorders treated with fludarabine-melphalan reduced-intensity conditioning allogeneic bone marrow stem cell transplantation.
    Malladi, RK
    Peniket, AJ
    Norton, AE
    Samol, J
    Campbell, AJ
    Jones, J
    Keen-McGuire, A
    Littlewood, TJ
    BLOOD, 2003, 102 (11) : 469B - 469B
  • [16] Reduced-intensity conditioning with treosulfan and fludarabine prior to allogeneic stem cell transplantation in multiple myeloma patients
    Schmidt-Hieber, M
    Casper, J
    Trenschel, R
    Andreesen, R
    Einsele, H
    Kanz, L
    Fauser, A
    Uharek, L
    Thiel, E
    Blau, I
    BONE MARROW TRANSPLANTATION, 2006, 37 : S195 - S196
  • [17] Targeted Marrow Irradiation Intensification of Reduced-Intensity Fludarabine/Busulfan Conditioning for Allogeneic Hematopoietic Stem Cell Transplantation
    Ali, Naveed
    Sharma, Ashish Arunkumar
    Pires de Rezende, Ana Carolina
    Otegbeye, Folashade
    Latif, Bilal Muhammad
    Kerbauy, Mariana Nassif
    Cooper, Brenda W.
    Sanchez, Gabriela
    Metheny, Leland
    Bal, Saswat K.
    Sakuraba, Roberto
    Tomlinson, Benjamin K.
    Boughan, Kirsten M.
    Kerbauy, Lucila
    Malek, Ehsan
    Ribeiro, Andreza Feitosa
    Gallogly, Molly
    Mansur, David
    Pereira, Gisele
    Weltman, Eduardo
    Sekaly, Rafick-Pierre
    de Lima, Marcos
    Caimi, Paolo F.
    Hamerschlak, Nelson
    TRANSPLANTATION AND CELLULAR THERAPY, 2022, 28 (07): : 370.e1 - 370.e10
  • [18] Gemcitabine, Fludarabine; and Melphalan for Reduced-Intensity Conditioning and Allogeneic Stem Cell Transplantation for Relapsed and Refractory Hodgkin Lymphoma
    Anderlini, Paolo
    Saliba, Rima M.
    Ledesma, Celina
    Plair, Tamera
    Alousi, Amin M.
    Hosing, Chitra M.
    Khouri, Issa F.
    Nieto, Yago
    Popat, Uday R.
    Shpall, Elizabeth J.
    Fanale, Michelle A.
    Hagemeister, Frederick B.
    Oki, Yasuhiro
    Neelapu, Saatva
    Romaguera, Jorge E.
    Younes, Anas
    Champlin, Richard E.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (07) : 1333 - 1337
  • [19] Allogeneic stem-cell transplantation after a myeloablative reduced-intensity conditioning regimen with fludarabine, busulfan and antithymocyte globulin in patients older than 45 years
    Martineau, D.
    Tabrizi, R.
    Pigneux, A.
    Bouabdallah, K.
    Leguay, T.
    Dilhuydy, M.
    Lascaux, A.
    Duclos, C.
    Marit, G.
    Milpied, N.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S527 - S527
  • [20] Reduced-intensity conditioning with fludarabine/busulfan versus fludarabine/low-dose melphalan in patients with non-Hodgkin lymphoma undergoing allogeneic haematopoietic stem cell transplantation
    Kamijo, Kimimori
    Shimomura, Yoshimitsu
    Kim, Sung-Won
    Ohigashi, Hiroyuki
    Ishikawa, Jun
    Eto, Tetsuya
    Hiramoto, Nobuhiro
    Mizuno, Ishikazu
    Iida, Shinsuke
    Ueda, Yasunori
    Matsuoka, Ken-ichi
    Yakushijin, Kimikazu
    Mori, Yasuo
    Onizuka, Makoto
    Fukuda, Takahiro
    Atsuta, Yoshiko
    Kako, Shinichi
    BRITISH JOURNAL OF HAEMATOLOGY, 2024, 205 (03) : 1097 - 1107
12345